Hepatoburn, a condition characterized by inflammation in the liver, presents several set of factors that contribute to its development. Genetic predisposition play a role in vulnerability, while obesity can exacerbate the condition. Management of hepatoburn typically involves a multi-pronged approach, including pharmacological interventions. Reduc